] i that were comparable to those produced by cholinergic receptors alone. Our data showing the selective expression of chloride co-transporters and the resulting strongly depolarized anion reversal potential may help explain how activation of GABA A receptors causes sufficient excitation to elicit catecholamine release from chromaffin cells.
I N T R O D U C T I O N
The neurotransmitter GABA activates ionotropic Cl Ϫ permeable GABA A receptors. Although GABA functions as the primary inhibitory neurotransmitter in the adult brain, in some neurons it is excitatory. GABA's effect is determined by the transmembrane Cl Ϫ gradient and the resulting chloride equilibrium potential (E Cl ) (Staley et al. 1996) . During development, GABA A mediated depolarization has been observed in many regions of the CNS (Ben-Ari 2002) . In these cells, the depolarized E Cl observed is due to, at least in some cases, a member of the Na ϩ -K ϩ -2Cl Ϫ (NKCC) co-transporter family (Alvarez-Leefmans et al. 1988; Rohrbough and Spitzer 1996; Sun and Murali 1999) , which driven by Na ϩ and K ϩ gradients, acts to accumulate intracellular Cl Ϫ (Ben-Ari 2002). Expression of a different co-transporter, KCC2 (K ϩ /Cl Ϫ ) (Payne et al. 1996) , which normally lowers intracellular Cl Ϫ , appears to mediate the developmental shift toward inhibition (Ben-Ari 2002; Owens and Kriegstein 2002; Rivera et al. 1999) . Embryonic animals appear to have limited expression of KCC2 and consequently exhibit elevated [Cl Ϫ ] i . As KCC2 expression increases with developmental age, excitatory GABA responses become inhibitory. Interestingly, depolarizing GABA A actions can even be observed in some adult neurons (Alvarez- Leefmans et al. 1988; Staley et al. 1996) .
GABA immunoreactive cells are found in the adrenal gland (Oomori et al. 1993) . Chromaffin cells possess the enzymes that synthesize and degrade GABA (Fernandez-Ramil et al. 1983; Kataoka et al. 1984) . GABA is taken up by chromaffin cells and is released in response to depolarizing stimuli (Kataoka et al. 1984; Oset Gasque et al. 1985) . GABA immunoreactive nerve fibers are found throughout the adrenal medulla (Kataoka et al. 1986; Oomori et al. 1993) . Chromaffin cells are known to express functional GABA A receptors with properties similar to their neuronal counterparts (Amenta et al. 1988; Bormann and Clapham 1985) . Sangiah et al. (1974) first showed that GABA could elicit catecholamine release from isolated perfused adrenal glands, a result that has been repeated (Fujimoto et al. 1987; Kataoka et al. 1984; Kitayama et al. 1984) . Even though a variety of studies have demonstrated that GABA depolarizes chromaffin cells, there is still a question of whether the net effect of GABA is excitatory or inhibitory; some studies suggest that GABA acts to inhibit excitation produced by acetylcholine (Ach) or high K ϩ (Fujimoto et al. 1987; Kataoka et al. 1986) , while other studies suggest that GABA facilitates stimulation evoked release (Kitayama et al. 1990c (Kitayama et al. , 1991 .
Here we describe the actions of GABA in juvenile chromaffin cells and explore the molecular mechanisms underlying these actions. Exposing these cells to GABA caused a large and rapid elevation in [Ca 2ϩ ] i , which required Ca 2ϩ influx from the extracellular space. The elevation of [Ca 2ϩ ] i required the activation of GABA A receptors; the action was mimicked by the selective GABA A agonist muscimol and blocked by the selective GABA A antagonist bicuculline. Exposing chromaffin cells to muscimol elicited significant catecholamine secretion. The extrapolated anion equilibrium potential of approximately Ϫ28 mV requires an equivalent intracellular Cl Ϫ concentration of approximately 50 mM (although both chloride and bicarbonate contribute to the anion reversal potential, HCO 3 effects were minimized by the use of HEPES buffered solutions and because solutions were not bubbled with CO 2 -containing gases). These results suggest that GABA A receptors are capable of strongly depolarizing chromaffin cells leading to opening of voltage-gated calcium channels. We show that chromaffin cells expressed NKCC1 protein and not KCC2 protein, a result which provides the molecular underpinning for the elevated [Cl Ϫ ] i levels observed. Consistent with these observations, blockade of NKCC1 with bumetanide significantly shifted E Cl , as measured by changes in [Ca 2ϩ ] i . As discussed above, there is still considerable debate about whether activation of GABA A receptors in chromaffin cells inhibits the excitation produced by the physiological activator of chromaffin cells, ACh (Fujimoto et al. 1987; Kataoka et al. 1986; Kitayama et al. 1990c Kitayama et al. , 1991 . Our results suggest that activation of GABA A receptors in chromaffin cells is excitatory under all conditions.
M E T H O D S

Cell culture
Juvenile bovine adrenal glands, from 4-to 5-mo-old animals, were obtained from a local slaughterhouse, and chromaffin cells were prepared by digestion with collagenase followed by density gradient centrifugation as previously described. The cells were plated onto collagen coated coverslips (at a density of 0.15-0.2 ϫ 10 6 cells/ml for electrophysiology experiments and 0.3-0.4 ϫ 10 6 cells/ml for [Ca 2ϩ ] i measurements) and maintained in an incubator at 37°C in an atmosphere of 93% O 2 -7% CO 2 with a relative humidity of 90%. Fibroblasts were effectively suppressed with cytosine-arabinoside (10 M), leaving relatively pure chromaffin cell cultures. One-half of the culture medium was exchanged every day. This medium consisted of DMEM / F12 (1:1) (Gibco) supplemented with fetal bovine serum (10%), glutamine (2 mM), penicillin/streptomycin (100 unit/ml per 100 g/ml), cytosine arabinoside (10 M), and 5-fluorodeoxyuridine (10 M).
[Ca 2ϩ ] i measurements
Experiments were conducted 1-5 days after chromaffin cells were prepared. Cells were incubated in HBSS with 2 M fura-2 AM and 1 mg/ml albumin for 45 min and washed in a fura-2-free solution for 1 h. Fura-2 loading and wash was carried out at 37°C. The coverslip was transferred to an experimental chamber for recording. Backgrounds at 340 and 380 nm were obtained using an area of the coverslip devoid of cells. Data were continuously collected throughout the experiment. On each coverslip, 10 -40 chromaffin cells were selected and individually imaged. Image pairs (1 at 340 and 380 nm) were obtained every 2 s by averaging 16 frames at each wavelength. Backgrounds were subtracted from the individual wavelengths, and the 340-nm image was divided by the 380-nm image to provide a ratiometric image. Ratios were converted to free [Ca 2ϩ ] i by comparing data to fura-2 calibration curves made in vitro by adding fura-2 (50 M free acid) to solutions that contained known concentrations of calcium (0 -2,000 nM). The recording chamber was continually perfused with fresh solution from gravity fed reservoirs.
Electrophysiology
Cells were voltage clamped using an Axopatch 1D amplifier and custom written Axobasic software in the gramicidin perforated whole cell configuration. Electrodes were pulled from microhematocrit capillary tubes (Drummond Scientific, Broomall, PA) and coated with Sylgard (Dow Corning, Midland, MI). After fire polishing, electrodes had resistances of Ͻ2 M⍀. Electrodes tips were briefly dipped in gramicidin-free patch pipette solution to fill the tip; gramicidin (50 g/ml) containing solution was used to backfill the electrode. After seal formation, gramicidin was slowly inserted into the membrane, and the series resistance was monitored by applying 20-mV steps (from a holding potential of -91 mV) to the cell every 15-20 s. The mean series resistance was 18.4 Ϯ 4.8 M⍀ (n ϭ 5). Most of the series resistance was compensated using the compensation circuitry of the Axopatch-1D amplifier. No further correction was applied to the data as the currents were typically small. During experiments, cells were voltage clamped at a holding potential of -91 mV, and the recording bath (total volume Ϸ 250 -300 l) was continually washed with fresh extracellular medium at a rate of 3-4 ml/min from gravity-fed reservoirs. Inward GABA A receptor currents were elicited by continual perfusion of a supramaximal dose of muscimol (100 M). Ramp depolarizations (l00 ms duration from -101 to -51 mV) were applied under control conditions and at the peak of the current elicited by muscimol (see Fig. 6 ). Currents generated by the ramps were filtered at 2 kHz and sampled every 100 s. A second computer running Axotape software was used to continually acquire data for 1-min episodes (sampling every 100 or 200 s) to capture the inward current response to muscimol application.
Amperometric measurement of catecholamine release
Cells were plated approximately five times more densely for these experiments than for the electrophysiology experiments. The recording bath was designed so that it was small (Ͻ1 cm diam), and the volume of the bath was kept at around 300 -350 l. Carbon fiber electrodes (Dagan Instruments) were backfilled with 3 M KCl and held at a potential of ϩ700 mV using a modified Warner PC-501 patch clamp amplifier. Electrodes were positioned within the bathing medium. In this configuration, the electrode detected increases in the local catecholamine concentration due to release from neighboring cells. Amperometric data from the patch clamp was recorded continuously using AxoTape (an 8-pole Bessel filter was set at 300 -500 Hz and acquired at 1-5 kHz). The cells were continually washed with HBSS for several minutes prior to application of muscimol or high-K ϩ containing solutions. Under control conditions (HBSS), stopping the flow of the solution in recording bath for 90 -120 s did not produce any change in amperometric current, indicating that the cells were not releasing appreciable amounts of catecholamine under basal conditions. Cells were stimulated by stopping the flow of the bath solution for 15-30 s and directly applying a 50-l bolus of one of the following: HBSS (negative control), high K ϩ (50 mM; positive control), or muscimol (100 M; final bath concentration of approximately 20 M). After 30 -60 s, the flow of HBSS through the bath was resumed to wash away the drug and any released catecholamine. A known concentration of noradrenaline was applied to the electrode in the absence of any cells to calibrate the response.
Solutions
Experiments were carried out in HBSS (Gibco) that contained (in mM) 138 NaCl, (pH 7.3) . Bumetanide was prepared as a 1-M stock in DMSO and diluted to 10 M with HBSS for pretreatment of the cells. For electrophysiological recordings, the cells were bathed in an extracellular solution that consisted of (in mM) 145 NaCl, 2 KCl, 1 MgCl 2 , 10 glucose, 10 HEPES, and 2 CaCl 2 (pH 7.3; Ϸ305-310 mOsm). The patch pipette solution consisted of (in mM) 145 Cs-glutamate, 9.5 NaCl, 0.5 TEA Cl, and 10 HEPES (pH 7.3; Ϸ300 -305 mOsm). These solutions produced a junction potential of approximately Ϫ11 mV, which has been corrected throughout the paper. Gramicidin was prepared at a stock concentration of 10 mg/ml in DMSO daily, and aliquots were diluted in the patch pipette solution and sonicated immediately prior to use (final concentration ϭ 50 g/ml). For the amperometry experiments, the bath contained HBSS. All experiments were carried out at room temperature (ϳ23°C).
Expression of KCC2 and NKCC1
Expression of KCC2 and NKCC1 in bovine chromaffin cells was determined by immunoblotting of chromaffin cell membranes prepared as described by Williams et al. (1999) . Bovine brain membranes were prepared in the same way to ensure that the antibodies recognized the bovine forms of both KCC2 and NKCC1. Membranes proteins (10 g) were separated by SDS-PAGE and transferred to Immobilon P by standard procedures. For detection of NKCC1, a monoclonal antibody against NKCC1 (T4, Developmental Studies Hybridoma Bank, The University of Iowa) was used at a dilution of 1:20,000, followed by an anti-mouse IgG-horseradish peroxidasecoupled secondary antibody (Jackson ImmunoResearch Laboratories) used at a dilution of 1:150,000. For detection of KCC2, a polyclonal rabbit antibody (Upstate Biotechnology 07-285) was used at a dilution of 1:3,000, followed by an anti-rabbit IgG-horseradish peroxidasecoupled secondary antibody (Jackson ImmunoResearch Laboratories) used at a dilution of 1:100,000. Bound antibody was detected using the ECL Advance System (Amersham).
R E S U L T S
Exposing chromaffin cells to GABA elevates intracellular calcium
Chromaffin cells were studied after 1-5 days in primary culture. A coverslip containing fura-2-loaded cells was transferred to an experimental chamber for each experiment. A field of cells was imaged, and [Ca 2ϩ ] i measurements from 10 -40 cells per coverslip were collected every 2 s. Figure 1A plots the mean [Ca 2ϩ ] i and SE averaged from 16 cells. Cells were perfused with a Ca 2ϩ -containing HBSS solution (see METHODS) and exposed three times to 100 M GABA as indicated in Fig.  1 . The first exposure to GABA elevated [Ca 2ϩ ] i by about 400 nM (Fig. 1A) . After removal of extracellular Ca 2ϩ , application of GABA was without effect. When Ca 2ϩ -containing HBSS was reintroduced into the bath, subsequent exposure to GABA produced a somewhat smaller, but significant, elevation in [Ca 2ϩ ] i (Fig. 1A) . The mean change in [Ca 2ϩ ] i elicited by 100 M GABA in Ca 2ϩ -containing HBSS was 441 Ϯ 19 nM (n ϭ 48), while no change in [Ca 2ϩ ] i was observed when GABA was applied in Ca 2ϩ -free solution. These data suggest that GABA elicits an elevation of [Ca 2ϩ ] i that requires the influx of extracellular Ca 2ϩ .
GABA A receptors mediate the elevation of [Ca 2ϩ ] i observed
The pharmacology of the GABA effect was explored in greater detail using agonists and antagonists specific for the GABA A receptor. Superfusion of the chromaffin cells with the GABA A agonist muscimol (5 M) produced an elevation in [Ca 2ϩ ] i of Ͼ400 nM when applied in Ca 2ϩ -containing HBSS (Fig. 1B) . When the bath solution was subsequently changed to Ca ] i in 23 individual chromaffin cells was determined every 2 s. Cells were exposed to muscimol (5 M), a specific GABA A receptor agonist, during the times indicated. Muscimol was 1st added to the bath in Ca elevation of [Ca 2ϩ ] i (Fig. 1B) . The average change in [Ca 2ϩ ] i elicited by application of muscimol (5 M) in Ca 2ϩ -containing solution was 361 Ϯ 70 nM (n ϭ 44), while in the Ca 2ϩ -free solution, no change in [Ca 2ϩ ] i was observed. This result suggests that muscimol and GABA elevate [Ca 2ϩ ] i by the activation of ionotropic GABA A receptors known to exist in bovine chromaffin cells (Bormann and Clapham 1985; Peters et al. 1989) .
To further verify the involvement of GABA A receptors, the specific GABA A receptor antagonist bicuculline was applied to chromaffin cells to block the response to muscimol. In the presence of bicuculline, the response to muscimol was completely blocked ( Fig. 2A) . Partial recovery of the response to muscimol was observed on washout of the bicuculline (data not shown). Muscimol (5 M) produced an average elevation in [Ca 2ϩ ] i of 335 Ϯ 26 nM (n ϭ 44) when applied in the absence of bicuculline, but this increase was almost completely blocked, to 11.9 Ϯ 2.4 nM, by bicuculline (Fig. 2B) . These data clearly demonstrate that activation of GABA A receptors in chromaffin cells are responsible for large elevations in [Ca 2ϩ ] i . 
Evidence of a depolarized anion equilibrium potential in chromaffin cells
For GABA to depolarize a cell sufficiently to activate voltage-dependent Ca 2ϩ channels, it appears that intracellular chloride levels must be high. To test this hypothesis, we altered the Cl Ϫ reversal potential by replacing most of the extracellular Cl Ϫ with SCN Ϫ , an anion that is more permeant in GABA A receptors and other chloride channels than Cl Ϫ itself (Bormann et al. 1987; Currie et al. 1995) . Replacing Cl Ϫ with SCN Ϫ anions typically results in a negative shift in the anion equilibrium potential. If the shift in the anion reversal potential is large enough, it would preclude activation of voltage-dependent Ca 2ϩ channels in response to muscimol. Indeed, when cells were exposed to 5 M muscimol in the presence of SCN Ϫ (140 mM), only a small elevation of [Ca 2ϩ ] i was observed (Fig. 4A) . The mean response of chromaffin cells to muscimol in a solution containing SCN Ϫ was an elevation in [Ca 2ϩ ] i of 38.2 Ϯ 6.8 nM, but an elevation in [Ca 2ϩ ] i of 377.9 Ϯ 25.8 nM (n ϭ 51) was observed when applied in HBSS (Fig. 4B) . These data support the idea that the chloride equilibrium potential of the cells is such that application of muscimol produces a depolarization that is strong enough to activate voltage-dependent Ca 2ϩ channels. To further explore this hypothesis, the response to muscimol in chromaffin cells was studied using perforated whole cell patch-clamp conditions. Anion impermeant gramicidin channels were used as the perforating agent to keep intracellular Cl Ϫ intact. Figure 5A shows that muscimol elicited an inward current that decayed with time in cells voltage clamped at Ϫ101 mV. As the current peaked, a voltage ramp from Ϫ101 to Ϫ51 mV (after correction for junction potential; inset) was applied to the cell. Ramp currents obtained in the presence and absence of muscimol are plotted in Fig. 5B . Note that without muscimol present, virtually no current was observed in the voltage range tested. In this range, neither Na ϩ nor Ca 2ϩ channels are active and K ϩ channels were blocked with Cs ϩ in the pipette. The difference between the "control" current and the current observed with "muscimol" in the bath represents the GABA A receptor current. The mean normalized current amplitude as a function of voltage (normalized I-V) from five such cells is plotted in Fig.  5C . In this data set, "control" voltage-ramp currents have been subtracted from "muscimol" voltage-ramp currents to remove any current not activated by muscimol. Because current amplitude varied between cells, all currents were normalized to that observed at Ϫ101 mV. In the range of Ϫ101 to Ϫ51 mV, the normalized I-V appears to be linear. Extrapolation of the I-V predicts a chloride reversal potential of Ϫ28 Ϯ 4 mV, which in turn suggests an intracellular chloride concentration of approximately 50 mM. Because the resting membrane potentials of chromaffin cells is typically in the range of -50 to -65 mV, it is expected that GABA A receptor activation would depolarize the cells. ] i in chromaffin cells exposed to 5 M muscimol in HBSS solution was 377.9 Ϯ 25.8 nM (n ϭ 51). When muscimol was applied during superfusion with 140 mM SCN Ϫ , the increase was only 38.2 Ϯ 6.8 nM.
Catecholamine secretion in response to muscimol
The robust elevations of [Ca 2ϩ ] i observed on exposing cells to either GABA or muscimol suggest that activation of GABA A receptors may be able to elicit catecholamine secretion in chromaffin cells. To test this hypothesis, amperometry was used to measure catecholamine release. An amperometric electrode was positioned inside a small bath, adjacent to a group of chromaffin cells, and was used to oxidize and thereby detect catecholamines released into the bath. Catecholamine release was measured after each of three different solutions were introduced into the bath: 50 mM K ϩ (high K ϩ ; top), control HBSS solution (middle), or muscimol in HBSS (Fig.  6A ). Experiments were performed in a static bath because rapid perfusion of fresh solution through the recording chamber rapidly dilutes and washes away secreted catecholamines. With the flow stopped, catecholamines released by the cells accumulate rapidly in the bath. Figure 6 shows that under control conditions (HBSS), there was no increase in bath catecholamine concentration. With the flow of solution through the bath stopped, both KCl and muscimol caused release of catecholamines that accumulated in the bath and led to an increase in the amperometric current recorded by the carbon fiber electrode. Resuming the flow of solution rapidly washed the released catecholamines out of the bath causing the amperomet- 
FIG. 5. Measurement of the Cl
Ϫ equilibrium potential in chromaffin cells. A: whole cell currents in a gramicidin-perforated cell voltage clamped at Ϫ101 mV. Washing muscimol into the bath (as indicated) elicited an inward current that decayed with time. Delay from onset of application to activation of the inward current was due to the "dead space" in the perfusion line. As the current peaked, a voltage-ramp from Ϫ101 to Ϫ51 mV (inset), was applied. B: whole cell currents elicited by voltage ramps in the presence and absence of muscimol. Difference between the "control" current and the current observed with "muscimol" in the bath represents the GABA A receptor current. C: normalized current as a function of voltage. Data were averaged from 5 cells similar to that shown in Fig. 7B . All currents were normalized to that observed at Ϫ101 mV. In the range of Ϫ101 to Ϫ51 mV, the normalized I-V appears to be linear. Extrapolation of the I-V predicts a chloride reversal potential of Ϫ28 Ϯ 4 mV. ric current to return to baseline. Mean data from five experiments are shown in Fig. 6B and illustrate that muscimol, although not as effective as KCl, produces significant release of catecholamines from chromaffin cells. Thus in addition to elevating [Ca 2ϩ ] i , activation of GABA A receptors also promotes the release of catecholamines in chromaffin cells.
Expression of KCC2 and NKCC1 co-transporters
In many embryonic neurons, GABA is an excitatory neurotransmitter, due to the high levels of intracellular Cl Ϫ found in these cells. After birth, the Cl Ϫ reversal potential changes to more negative potentials, in many cases due to expression of the K ϩ -Cl -co-transporter KCC2. Although the bovine chromaffin cells used in this study were from juvenile and not embryonic animals, the elevated [Cl Ϫ ] i suggests that these cells do not express the KCC2 transporter. To determine whether KCC2 is expressed in chromaffin cells, membrane proteins from the chromaffin cells and from bovine brain were separated by SDS-PAGE, transferred to polyvinylidene fluoride membranes, and probed with a polyclonal antibody to KCC2. A protein of the appropriate size for KCC2 (approximately 140 kDa) was observed in brain membranes but not in membranes from chromaffin cells (Fig. 7A ). This indicates that KCC2 is not expressed in bovine chromaffin cells.
In many cases, expression of the NKCC1 co-transporter plays a role in the high Cl Ϫ levels observed. To determine whether NKCC1 is expressed in chromaffin cells, immunoblotting was carried out as described for KCC2. Proteins of the appropriate size for NKCC1 (approximately 180 kDa) were detected in both chromaffin cell membranes and bovine brain membranes. (Fig. 7A) . These results indicate that NKCC1 is expressed in bovine chromaffin cells.
If NKCC1 is involved in maintaining the high [Cl Ϫ ] i necessary for the depolarizing effects of muscimol, inhibition of NKCC1 should reduce the ability of muscimol to raise [Ca 2ϩ ] i . Therefore we tested the ability of bumetanide, an inhibitor of NKCC1 to inhibit the effects of muscimol. One group of cells was pre-exposed to bumetanide (10 M) for 3 h, while a second group was not. Muscimol was then applied to both groups of cells. [Ca 2ϩ ] i was elevated by 299.3 Ϯ 20.1 nM (n ϭ 67) in control cells treated with muscimol but was elevated by only 169.5 Ϯ 19.7 (n ϭ 75; P Ͻ 0.01) in cells pre-exposed to bumetanide (Fig. 7B) . Note that the baseline [Ca 2ϩ ] i , prior to muscimol exposure was not different in either case (data not shown). Three-hour exposures to DMSO, the carrier for bumetanide, did not affect responses to muscimol {change in [Ca 2ϩ ] i to muscimol plus DMSO was 239.31 Ϯ 35.60 (n ϭ 9), while control change in response to muscimol alone was 252.99 Ϯ 37.46 (n ϭ 12)}. In addition, high-K ϩ depolarizations produced virtually identical Ca 2ϩ transients in both groups of cells, indicating that the voltage-dependent Ca 2ϩ channels and intracellular Ca 2ϩ buffering machinery were unaffected by bumetanide.
Co-activation of ACh and GABA A receptors
ACh released by presynaptic splanchnic nerve terminals is thought to be the physiological activator of adrenal chromaffin cells. In some cells, activation of GABA A receptors is depolarizing but is still inhibitory (Zhang and Jackson 1993) . In chromaffin cells, there is considerable controversy whether GABA can inhibit responses to high K ϩ or ACh, even though GABA itself is excitatory (Fujimoto et al. 1987; Kataoka et al. 1986; Kitayama et al. 1990c Kitayama et al. , 1991 . To address this issue, we examined elevations in [Ca 2ϩ ] i in response to ACh, in the presence and absence of muscimol, to determine whether activation of GABA A receptors would inhibit the response to ACh. As shown in Fig. 8, responses to ACh (100 M; a nonsaturating concentration) were virtually identical in the FIG. 7. Bovine chromaffin cells express NKCC1 but not KCC2. A: immunoblot using chromaffin cell membranes and bovine brain membranes (10 g per lane, except for the last lane which was 25 g). Lanes 1 and 2 were probed with an antibody to NKCC1, and lanes 3-5 were probed with an antibody to KCC2. NKCC1 (ϳ185 kDa) was detected in both chromaffin cells and bovine brain. Doublet seen with brain may represent different glycosylated forms of the protein. KCC2 (ϳ140 kDa) was detected only in brain even when more than twice as much chromaffin cell membrane protein was applied to the SDS-PAGE gel. B: [Ca 2ϩ ] i was measured in control chromaffin cells or cells pre-exposed to bumetanide (10 M) for 3 h. Increases in [Ca 2ϩ ] i in response to muscimol were significantly smaller in cells pre-exposed to bumetanide. Bumetanide is a blocker of NKCC1 transporter, and its ability to partially block the effects of muscimol suggests that the effects of muscimol depend on the activity of NKCC1. High K ϩ depolarizations produced virtually identical increases in [Ca presence or absence of muscimol. The order of presentation of ACh or ACh plus muscimol did not affect the responses (see Fig. 8, A and B) . In addition, applying muscimol 2 min prior to ACh application did not alter the response (data not shown). In this set of experiments, ACh elevated [Ca 2ϩ ] i by 771 Ϯ 11 nM in the absence of muscimol and by 748 Ϯ 8 nM in the presence of muscimol (n ϭ 59).
D I S C U S S I O N
Here we describe the molecular mechanism by which GABA produces excitation of adrenal chromaffin cells. Several lines of evidence suggest that GABA may play an important role in the physiology of the adrenal medulla; chromaffin cells possess the enzymes that synthesize and degrade GABA (Fernandez-Ramil et al. 1983; Kataoka et al. 1984) ; GABA is taken up by chromaffin cells and released in response to depolarizing stimuli (Kataoka et al. 1984; Oset Gasque et al. 1985 , 1990 ; GABA immunoreactive nerve fibers are found throughout the adrenal medulla (Kataoka et al. 1986; Oomori et al. 1993 ) and bundles of GABA immunoreactive nerve fibers run into the medulla with varicosities often in close contact with chromaffin cells (Kataoka et al. 1986; Oomori et al. 1993 ); chromaffin cells express GABA A receptors (Amenta et al. 1988; Bormann and Clapham 1985; Peters et al. 1989) ; and immunoblots indicate the presence of ␣1, ␣4, ␤1-3, and ␥2 subunits (Parramon et al. 1995a ). Functionally it has been shown that GABA can elicit catecholamine release from isolated perfused adrenal glands (Fujimoto et al. 1987; Gonzalez et al. 1992; Kataoka et al. 1984; Kitayama et al. 1984; Sangiah et al. 1974) . Consistent with earlier studies (Doroshenko 1989; Kitayama et al. 1990a; Gonzalez et al. 1992 Ionotropic GABA A receptors are usually associated with inhibition, but during development, GABA A mediated depolarization has been observed in many regions of the CNS (Ben-Ari 2002; Chen et al. 1996; Eilers et al. 2001; Luhmann and Prince 1991; Mueller et al. 1984; Owens et al. 1996; Yuste and Katz 1991) . The action of GABA A receptors in neurons is determined by the transmembrane Cl Ϫ gradient and the resultant E Cl (Staley et al. 1996) . The depolarized E Cl observed is due to, at least in some cases, a member of the NKCC cotransporter family (Alvarez-Leefmans et al. 1988; Rohrbough and Spitzer 1996; Sun and Murali 1999) , which driven by Na ϩ and K ϩ gradients, acts to accumulate intracellular Cl Ϫ (BenAri 2002). Expression of another co-transporter that normally lowers intracellular Cl Ϫ , KCC2 (Payne et al. 1996) , appears to mediate the developmental shift toward inhibition (Ben-Ari 2002; Owens and Kriegstein 2002; Rivera et al. 1999) . Embryonic animals have limited expression of KCC2 and consequently exhibit elevated [Cl Ϫ ] i . As KCC2 expression increases with developmental age, excitatory GABA responses become inhibitory, although the developmental stage at which KCC2 expression increases varies somewhat in different neurons (Mikawa et al. 2002) . The juvenile animals used in our study are 4-to 6-mo-old and are quite mature. They should be similar to adult animals in terms of the switch in neuronal KCC2. Interestingly, depolarizing GABA A responses have also been observed in some adult neurons. Dorsal root ganglion neurons exhibit depolarizing GABA responses as E Cl is 50 mV more depolarized than the cellular resting potential (Alvarez- Leefmans et al. 1988; Staley et al. 1996; Sung et al. 2000) . In the retina, KCC2 is expressed in neurons where GABA is inhibitory, whereas NKCC is expressed in neurons where GABA is excitatory (Vardi et al. 2000) .
The results from neurons suggest that the excitatory responses of chromaffin cells to GABA could be due to depolarization because of elevated [ ] i levels. Furthermore, pharmacological blockade of the NKCC1 co-transporter with bumetanide significantly inhibited the response to muscimol, most likely by altering E Cl . Although it has been reported that a different NKCC1 inhibitor furosemide can inhibit GABA A receptors at concentrations Ͼ1 mM (Nicoll 1978), we expect that bumetanide would be quite selective at the low concentration used in the current study. The inhibition by bumetanide, while significant, was incomplete probably because the dissipation of the intracellular anionic gradient was slow. We have no reason to doubt that bumetanide completely blocked NKCC1. Longer exposures to bumetanide gave progressively larger effects but very long exposures were technically difficult to do. So we compromised by using a 3-h exposure where we observed an incomplete response.
The role of GABA in the adrenal gland is still not well understood. There is even some debate as to whether GABA is truly excitatory in adrenal chromaffin cells. Several studies have suggested that GABA acts to inhibit excitation produced by other neurotransmitters (Fujimoto et al. 1987; Kataoka et al. 1986 ) and that activation of GABA A receptors at first lead to action potential generation, followed by the arrest of action potentials (Busik et al. 1996) . However, Kitayama et al. (1990c Kitayama et al. ( , 1991 showed that GABA facilitated catecholamine release elicited by ACh or high K ϩ . Earlier measurements in chromaffin cells placed E Cl at Ϫ51.4 mV (Gonzalez et al. 1992) , suggesting that GABA will depolarize chromaffin cells only weakly if at all. Our data suggest that GABA is excitatory under all conditions. Responses to ACh were not diminished by co-activation of GABA A receptors. Furthermore, we provide evidence that E Cl is much more depolarized than previously appreciated. Please note that any rectification of the channels would alter our estimated reversal potential but that it would be quite depolarized under all conditions.
It should also be noted that GABA responses are more complex than simply altering membrane potential. Activation of GABA A receptors induced c-Fos immunoreactivity and increased brain-derived neurotrophic factor (BDNF) mRNA expression in embryonic hippocampal neurons but failed to have any effect in older neurons (Berninger et al. 1995) . GABA stimulates DNA synthesis (Haydar et al. 2000; LoTurco et al. 1995) , and interestingly, appears to regulate KCC2 expression (Ganguly et al. 2001) . It is possible that GABA may mediate other effects in chromaffin cells, but this remains to be determined.
Several studies also implicate GABA B receptors in the actions of GABA on catecholamine secretion from chromaffin cells (Castro et al. 1989; Oset-Gasque et al. 1993; Parramon et al. 1995b) . Our own studies were not designed to investigate GABA B -mediated responses per se, but they suggest that GABA B receptors were not involved in the actions of GABA described in this paper. Activation of GABA B receptors mobilizes Ca 2ϩ from intracellular stores. Because it takes the intracellular stores in chromaffin cells quite a while to rundown in Ca 2ϩ -free solutions, we would expect a Ca 2ϩ -transient when GABA was applied in Ca 2ϩ -free solution if GABA B receptors were present. Because we saw no response, we concluded that most likely there were no GABA B receptors present in the cells. In mammals, GABA C receptors are only expressed in the retina and the subcortical visual system (Boller and Schmidt 2003) and are therefore unlikely to play a role in the responses reported here.
Overall, the physiological roles of GABA in the adrenal gland are likely to be complex and may involve actions on gene expression, control of membrane potential, calcium influx, and catecholamine release. Our data clearly support an exclusively excitatory role for GABA that is mediated through the selective expression of NKCC1 but not KCC2. It also suggests that clinically relevant drugs that interact with GABA A receptors including anesthetics and other neuroactive agents like benzodiazepines and barbiturates may have stimulatory effects on catecholamine release (Joyce et al. 1982; Kitayama et al. 1989) . Further studies will be needed to determine if this is the case and to elucidate other functional consequences of the elevated [Cl Ϫ ] found in chromaffin cells.
